Showing results (1-10 of 9) with videos related to
Sort By:
Pageof 1
Endocrinology|August 5, 1999
HMC-1 mast cells activate human orbital fibroblasts in coculture: evidence for up-regulation of prostaglandin E2 and hyaluronan synthesisT J Smith, S J ParikhThe Journal of Computed Tomography|December 1, 1981
The anomalous left renal vein: CT appearance and clinical implicationsS J Parikh, J C Peters, R H KihmJournal of Colloid and Interface Science|January 29, 2008
An ATR-FTIR spectroscopic approach for measuring rapid kinetics at the mineral/water interfaceS J Parikh, B J Lafferty, D L SparksIndian Heart Journal|September 1, 1989
Tricuspid valve replacement for gross tricuspid insufficiency due to dysplastic valve--a case reportR Magotra, N B Agrawal, S P Mall, et al.American Journal of Physiology. Cell Physiology|July 27, 2000
Functional TSH receptor in human abdominal preadipocytes and orbital fibroblastsA Bell, A Gagnon, L Grunder, et al.The Journal of Clinical Endocrinology and Metabolism|June 7, 2002
Comparison of insulin sensitivity, clearance, and secretion estimates using euglycemic and hyperglycemic clamps in childrenGabriel I Uwaifo, S J Parikh, M Keil, et al.The Japanese Dental Science Review|July 11, 2026
Exploring oxidative and antioxidant biomarkers in temporomandibular joint disorders: An exploratory systematic review across multiple biological fluidsYukta Saxena, Piyush G Limdiwala, J S Shah, et al.Deutsche Medizinische Wochenschrift (1946)|March 27, 2013
[Dapagliflozin versus glipizide as add-on therapy in patients with type 2 diabetes who have inadequate glycemic control with metformin]M Nauck, S del Prato, J J Meier, et al.Diabetes, Obesity & Metabolism|June 13, 2014
Durability of glycaemic efficacy over 2 years with dapagliflozin versus glipizide as add-on therapies in patients whose type 2 diabetes mellitus is inadequately controlled with metforminM A Nauck, S Del Prato, S Durán-García, et al.Pageof 1